表紙
市場調查報告書
商品編碼
1044790

無痛性甲狀腺炎的全球市場: 產業分析,市場規模,佔有率,成長,趨勢,預測(2020年∼2027年)

Global Silent Thyroiditis Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日期: | 出版商: Value Market Research | 英文 510 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球無痛性甲狀腺炎的市場規模在2021年∼2027年的預測期間內將達到大幅成長。

本報告提供全球無痛性甲狀腺炎市場相關調查分析,提供促進因素,阻礙因素,機會,產業分析,市場動態,市場分析,不同治療·診斷·劑量·各給藥途徑·各終端用戶·各流通管道·各地區的分析,競爭情形,企業簡介等系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 無痛性甲狀腺炎 - 產業分析

  • 簡介 - 市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主清單
  • 行銷流通管道

第5章 COVID-19的影響分析

  • COVID-19的影響分析
  • COVID-19影響分析:生產,進口,出口及各需求
  • 市場:COVID-19前和COVID-19後
  • COVID-19流行:估計影響
  • COVID-19:微及宏觀因素分析

第6章 全球無痛性甲狀腺炎市場分析:不同治療

  • 概要:不同治療
  • 履歷資料與預測資料
  • 分析:不同治療
  • β- 阻斷劑市場:各地區
  • 甲狀腺荷爾蒙補充市場:各地區
  • 其他的市場:各地區

第7章 全球無痛性甲狀腺炎市場分析:各診斷

  • 概要:各診斷
  • 履歷資料與預測資料
  • 分析:各診斷
  • 甲狀腺荷爾蒙T3·T4市場:各地區
  • TSH,放射性碘攝取市場:各地區
  • C反應性蛋白質市場:各地區
  • 紅血球沉澱速度市場:各地區
  • 其他的市場:各地區

第8章 全球無痛性甲狀腺炎市場分析:各劑量

  • 概要:各劑量
  • 履歷資料與預測資料
  • 分析:各劑量
  • 平板電腦市場:各地區
  • 注射市場:各地區
  • 其他的市場:各地區

第9章 全球無痛性甲狀腺炎市場分析:各給藥途徑

  • 概要:各給藥途徑
  • 履歷資料與預測資料
  • 分析:各給藥途徑
  • 口服市場:各地區
  • 靜脈注射市場:各地區
  • 其他的市場:各地區

第10章 全球無痛性甲狀腺炎市場分析:各終端用戶

  • 概要:各終端用戶
  • 履歷資料與預測資料
  • 分析:各終端用戶
  • 診所市場:各地區
  • 醫院市場:各地區
  • 其他的市場:各地區

第11章 全球無痛性甲狀腺炎市場分析:各流通管道

  • 概要:各流通管道
  • 履歷資料與預測資料
  • 分析:各流通管道
  • 醫院藥局市場:各地區
  • 零售藥局市場:各地區
  • 線上藥局市場:各地區

第12章 全球無痛性甲狀腺炎市場分析:各地區

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第13章 無痛性甲狀腺炎企業的競爭情形

  • 無痛性甲狀腺炎市場競爭
  • 夥伴關係/合作/契約
  • 合併·收購
  • 新產品的銷售
  • 其他的開發

第14章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Pierre Fabre Group
  • ANI Pharmaceuticals, Inc.
  • Mylan N.V.
  • Novartis AG
  • King Pharma
  • GlaxoSmithKline plc
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Sanofi
  • Lilly
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Merck Sharp & Dohme Corp.
目錄
Product Code: VMR11216702

Value Market Research's latest report on the Global Silent Thyroiditis Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global silent thyroiditis market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global silent thyroiditis market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global silent thyroiditis market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global silent thyroiditis market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global silent thyroiditis market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global silent thyroiditis market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global silent thyroiditis market.

The market analysis involves a section exclusively to list the major players of the global silent thyroiditis market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Silent Thyroiditis Market Report Segments the market as below:

By Treatment

  • Beta-blockers
  • Thyroid Hormone Replacement
  • Others

By Diagnosis

  • Thyroid hormones T3 and T4
  • TSH, Radioactive iodine uptake
  • C-reactive protein
  • Erythrocyte sedimentation rate
  • Others

By Dosage

  • Tablet
  • Injection
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Others

By End-Users

  • Clinic
  • Hospital
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SILENT THYROIDITIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Treatment
    • 3.7.2 By Diagnosis
    • 3.7.3 By Dosage
    • 3.7.4 By Route of Administration
    • 3.7.5 By End-Users
    • 3.7.6 By Distribution Channel
    • 3.7.7 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY TREATMENT

  • 6.1 Overview by Treatment
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Treatment
  • 6.4 Beta-blockers Market by Regions
  • 6.5 Thyroid Hormone Replacement Market by Regions
  • 6.6 Others Market by Regions

7 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY DIAGNOSIS

  • 7.1 Overview by Diagnosis
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Diagnosis
  • 7.4 Thyroid hormones T3 and T4 Market by Regions
  • 7.5 TSH, Radioactive Iodine Uptake Market by Regions
  • 7.6 C-reactive Protein Market by Regions
  • 7.7 Erythrocyte Sedimentation Rate Market by Regions
  • 7.8 Others Market by Regions

8 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY DOSAGE

  • 8.1 Overview by Dosage
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Dosage
  • 8.4 Tablet Market by Regions
  • 8.5 Injection Market by Regions
  • 8.6 Others Market by Regions

9 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 9.1 Overview by Route of Administration
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Route of Administration
  • 9.4 Oral Market by Regions
  • 9.5 Intravenous Market by Regions
  • 9.6 Others Market by Regions

10 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY END-USERS

  • 10.1 Overview by End-Users
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-Users
  • 10.4 Clinic Market by Regions
  • 10.5 Hospital Market by Regions
  • 10.6 Others Market by Regions

11 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 11.1 Overview by Distribution Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Distribution Channel
  • 11.4 Hospital Pharmacy Market by Regions
  • 11.5 Retail Pharmacy Market by Regions
  • 11.6 Online Pharmacy Market by Regions

12 . GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America
    • 12.3.1. Overview, Historic and Forecast Data
    • 12.3.2. North America By Segment
    • 12.3.3. North America By Country
    • 12.3.4. United State
    • 12.3.5. Canada
    • 12.3.6. Mexico
  • 12.4. Europe
    • 12.4.1. Overview, Historic and Forecast Data
    • 12.4.2. Europe by Segment
    • 12.4.3. Europe by Country
    • 12.4.4. United Kingdom
    • 12.4.5. France
    • 12.4.6. Germany
    • 12.4.7. Italy
    • 12.4.8. Russia
    • 12.4.9. Rest Of Europe
  • 12.5. Asia Pacific
    • 12.5.1. Overview, Historic and Forecast Data
    • 12.5.2. Asia Pacific by Segment
    • 12.5.3. Asia Pacific by Country
    • 12.5.4. China
    • 12.5.5. India
    • 12.5.6. Japan
    • 12.5.7. South Korea
    • 12.5.8. Australia
    • 12.5.9. Rest Of Asia Pacific
  • 12.6. Latin America
    • 12.6.1. Overview, Historic and Forecast Data
    • 12.6.2. Latin America by Segment
    • 12.6.3. Latin America by Country
    • 12.6.4. Brazil
    • 12.6.5. Argentina
    • 12.6.6. Peru
    • 12.6.7. Chile
    • 12.6.8. Rest of Latin America
  • 12.7. Middle East & Africa
    • 12.7.1. Overview, Historic and Forecast Data
    • 12.7.2. Middle East & Africa by Segment
    • 12.7.3. Middle East & Africa by Country
    • 12.7.4. Saudi Arabia
    • 12.7.5. UAE
    • 12.7.6. Israel
    • 12.7.7. South Africa
    • 12.7.8. Rest Of Middle East And Africa

13 . COMPETITIVE LANDSCAPE OF THE SILENT THYROIDITIS COMPANIES

  • 13.1. Silent Thyroiditis Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF SILENT THYROIDITIS INDUSTRY

  • 14.1. Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Pierre Fabre Group
    • 14.3.1. Company Overview
    • 14.3.2. Financials
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. ANI Pharmaceuticals, Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Financials
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. Mylan N.V.
    • 14.5.1. Company Overview
    • 14.5.2. Financials
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Novartis AG
    • 14.6.1. Company Overview
    • 14.6.2. Financials
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. King Pharma
    • 14.7.1. Company Overview
    • 14.7.2. Financials
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. GlaxoSmithKline plc
    • 14.8.1. Company Overview
    • 14.8.2. Financials
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Lupin
    • 14.9.1. Company Overview
    • 14.9.2. Financials
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Sun Pharmaceutical Industries Ltd.
    • 14.10.1. Company Overview
    • 14.10.2. Financials
    • 14.10.3. Products
    • 14.10.4. Recent Developments
  • 14.11. Teva Pharmaceutical Industries Ltd.
    • 14.11.1. Company Overview
    • 14.11.2. Financials
    • 14.11.3. Products
    • 14.11.4. Recent Developments
  • 14.12. Pfizer Inc.
    • 14.12.1. Company Overview
    • 14.12.2. Financials
    • 14.12.3. Products
    • 14.12.4. Recent Developments
  • 14.13. Sanofi
    • 14.13.1. Company Overview
    • 14.13.2. Financials
    • 14.13.3. Products
    • 14.13.4. Recent Developments
  • 14.14. Lilly
    • 14.14.1. Company Overview
    • 14.14.2. Financials
    • 14.14.3. Products
    • 14.14.4. Recent Developments
  • 14.15. AstraZeneca
    • 14.15.1. Company Overview
    • 14.15.2. Financials
    • 14.15.3. Products
    • 14.15.4. Recent Developments
  • 14.16. Johnson & Johnson Private Limited
    • 14.16.1. Company Overview
    • 14.16.2. Financials
    • 14.16.3. Products
    • 14.16.4. Recent Developments
  • 14.17. Bristol-Myers Squibb Company
    • 14.17.1. Company Overview
    • 14.17.2. Financials
    • 14.17.3. Products
    • 14.17.4. Recent Developments
  • 14.18. Bayer AG
    • 14.18.1. Company Overview
    • 14.18.2. Financials
    • 14.18.3. Products
    • 14.18.4. Recent Developments
  • 14.19. Merck Sharp & Dohme Corp.
    • 14.19.1. Company Overview
    • 14.19.2. Financials
    • 14.19.3. Products
    • 14.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Treatment (USD MN)
  • Beta-blockers Market by Geography (USD MN)
  • Thyroid Hormone Replacement Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Diagnosis (USD MN)
  • Thyroid hormones T3 and T4 Market by Geography (USD MN)
  • TSH, Radioactive Iodine Uptake Market by Geography (USD MN)
  • C-reactive Protein Market by Geography (USD MN)
  • Erythrocyte Sedimentation Rate Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Dosage (USD MN)
  • Tablet Market by Geography (USD MN)
  • Injection Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market by Geography (USD MN)
  • Intravenous Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by End-Users (USD MN)
  • Clinic Market by Geography (USD MN)
  • Hospital Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market by Geography (USD MN)
  • Retail Pharmacy Market by Geography (USD MN)
  • Online Pharmacy Market by Geography (USD MN)
  • Global Silent Thyroiditis Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Silent Thyroiditis Report
  • Market Research Process
  • Market Research Methodology
  • Global Silent Thyroiditis Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by Diagnosis
  • Market Attractiveness Analysis by Dosage
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by End-Users
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment (USD MN)
  • Beta-blockers Market by Geography (USD MN)
  • Thyroid Hormone Replacement Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Diagnosis (USD MN)
  • Thyroid hormones T3 and T4 Market by Geography (USD MN)
  • TSH, Radioactive Iodine Uptake Market by Geography (USD MN)
  • C-reactive Protein Market by Geography (USD MN)
  • Erythrocyte Sedimentation Rate Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Dosage (USD MN)
  • Tablet Market by Geography (USD MN)
  • Injection Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market by Geography (USD MN)
  • Intravenous Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by End-Users (USD MN)
  • Clinic Market by Geography (USD MN)
  • Hospital Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market by Geography (USD MN)
  • Retail Pharmacy Market by Geography (USD MN)
  • Online Pharmacy Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.